PRECISOCARE® manages the full genomic testing lifecycle — enrollment, ordering, sample tracking, lab coordination, results delivery, and longitudinal follow-up — within a single governed platform designed for institutional deployment.
Every stage of the genomic testing workflow is structured, logged, and actionable within PRECISOCARE®. Providers interact with a single operational platform rather than coordinating across disconnected systems.
Structured enrollment begins with eligibility screening against program-specific criteria. Digital consent workflows capture patient or guardian authorization with document storage and audit logging. Pre-test education materials are delivered at point of consent, ensuring patients understand what whole-genome sequencing involves, what it can and cannot identify, and how results will be used.
All consent workflows are program-specific and configurable to institutional requirements. Consent records are versioned, timestamped, and retrievable for compliance review. Pre-test genetic counseling referral triggers are built into enrollment for high-complexity cases.
Providers place orders through PRECISOCARE® with program-guided test selection and clinical indication documentation. Orders route automatically based on program logic — Newborn, Pediatric, Adult, or Senior — with appropriate specimen requirements, ICD code guidance, and lab routing pre-configured. Order confirmation, lab acknowledgement, and specimen receipt are all captured and visible in the provider dashboard.
Specimen collection follows program-specific protocols with step-by-step guidance for clinical staff. Sample identity, collection timestamp, collector identity, and handling conditions are documented at collection. Once shipped, PRECISOCARE® provides chain-of-custody tracking from collection point through laboratory receipt — with alerts for delays, temperature deviations, or specimen quality concerns.
Genomic testing on misidentified or compromised specimens generates results that can lead to incorrect clinical decisions. PRECISOCARE® chain-of-custody controls eliminate this risk category at the system level, not through manual process.
All genomic testing is processed through CLIA-certified and CAP-accredited laboratories. Whole-genome sequencing delivers the highest resolution diagnostic data available — covering single nucleotide variants (SNVs), copy number variants (CNVs), structural variants, indels, and mitochondrial variants in a single test. Laboratory turnaround time, QC status, and processing stage are visible within PRECISOCARE® throughout processing.
Results are delivered as provider-ready reports formatted for clinical decision-making — not raw genomic data requiring specialist interpretation. Findings are classified by clinical significance (Pathogenic, Likely Pathogenic, Variant of Uncertain Significance, Benign), annotated with recommended clinical actions, and prioritized by urgency. PHIN®-enabled coordination routes critical findings for immediate provider notification.
Every report section is designed to answer one question: "What should I do next?" Variant classifications align to ACMG/AMP criteria. PGx results map to CPIC prescribing guidelines. The report is a clinical tool, not a data dump.
Genomic data is longitudinal by nature — a variant identified today remains clinically relevant as new evidence emerges, as family members are tested, or as the patient progresses through different health states. PRECISOCARE® maintains the patient's genomic record across programs, providers, and time — enabling reinterpretation as classifications update, cascade family testing coordination, and continuity across the care continuum.
PHIN® (Predictiv Health Intelligence Network) is the coordination layer that connects PRECISOCARE® workflows to the broader clinical ecosystem — enabling intelligent routing of results, alerts, referrals, and follow-up actions.
Critical and urgent findings are routed immediately to the appropriate provider with alert logic that respects care team structure, role-based access controls, and escalation protocols.
Results requiring specialist review — genetics, cardiology, oncology, neurology — trigger structured referral workflows with relevant clinical context pre-populated for the receiving provider.
Program administrators and clinical leadership gain population-level dashboards — enrollment rates, results distribution, follow-up completion rates, and program compliance metrics.
Implementation planning begins with a workflow assessment. Request access to connect with the PRECISO team and map the platform to your existing clinical operations.